RegenKit® BCT produces A-PRP with an optimal cellular profile and platelet viability
RegenKit® A-PRP is composed of sterile disposable tubes, butterfly needle, transfer devices and syringes, packaged in a single-use double blister.
RegenKit® cell separator gel allows for the easy, rapid and consistent preparation, from a small volume of blood, of A-PRP with an optimal platelet concentration and viability.
Intended use of the device: Preparation of autologous platelet-rich plasma and other plasma-derived products.
A safe and effective leukocyte-reduced A_PRP
The patient’s platelet concentrate prepared with RegenKit®
Platelets are key factors in hard and soft tissue repair mechanisms (1). They provide essential growth factors, such as FGF, PDGF, TGF-ß, EGF, VEGF, IGF, which are involved in stem cell migration, differentiation and proliferation. Additionally, platelets also stimulate fibroblasts and endothelial cells to induce new extracellular matrix deposition and neo-vascularisation respectively. The platelets are concentrated from the patient’s own blood.
Plasma contains many factors essential for cell survival including nutrients, vitamins, hormones, electrolytes, growth factors (such as IGF and HGF), and proteins. Among the plasma proteins, the molecules vital for the coagulation process and for the fibrin polymer formation will serve as a scaffold for cell migration and new tissue generation.
RegenKit A-PRP is composed of sterile disposable tubes, butterfly needle, transfer devices and syringes, packaged in a single or double blister.
RegenKit cell separator gel allows for the easy, rapid and consistent preparation, from a small volume of blood, of A-PRP with an optimal platelet concentration and viability.
RegenKit BCT – Medical Device Class III – CE2797
RegenKit® A-PRP is composed of sterile disposable tubes, butterfly needle, transfer devices and syringes, packaged in a single-use double blister.
RegenKit® cell separator gel allows for the easy, rapid and consistent preparation, from a small volume of blood, of A-PRP with an optimal platelet concentration and viability.
Intended use of the device: Preparation of autologous platelet-rich plasma and other plasma-derived products.
A safe and effective leukocyte-reduced A_PRP
RegenKit BCT – Medical Device Class III – CE2797
The patient’s platelet concentrate prepared with RegenKit®
Platelets are key factors in hard and soft tissue repair mechanisms (1). They provide essential growth factors, such as FGF, PDGF, TGF-ß, EGF, VEGF, IGF, which are involved in stem cell migration, differentiation and proliferation. Additionally, platelets also stimulate fibroblasts and endothelial cells to induce new extracellular matrix deposition and neo-vascularisation respectively. The platelets are concentrated from the patient’s own blood.
Plasma contains many factors essential for cell survival including nutrients, vitamins, hormones, electrolytes, growth factors (such as IGF and HGF), and proteins. Among the plasma proteins, the molecules vital for the coagulation process and for the fibrin polymer formation will serve as a scaffold for cell migration and new tissue generation.
RegenKit A-PRP is composed of sterile disposable tubes, butterfly needle, transfer devices and syringes, packaged in a single or double blister.
RegenKit cell separator gel allows for the easy, rapid and consistent preparation, from a small volume of blood, of A-PRP with an optimal platelet concentration and viability.
JOINT OPERATIONS (UK) LLP
Unit 11 Interface Business Park
Bincknoll Lane
Royal Wootton Bassett
Wiltshire
SN4 8SY
UK
Company no. OC396027
VAT no. GB 198327955
OFFICE HOURS:
Mon - Fri 08:30 to 17:30
Tel. +44 (0) 1793 575 050
OUT OF HOURS BURNS SUPPORT:
Tel. +44 (0)1793 575 041